These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23568006)

  • 1. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2.
    Zhang C; Zhao Y; Zeng B
    Cancer Biomark; 2012; 12(4):155-67. PubMed ID: 23568006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing.
    Zhao Y; Zhang CL; Zeng BF; Wu XS; Gao TT; Oda Y
    Biochem Biophys Res Commun; 2009 Dec; 390(3):642-7. PubMed ID: 19818735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
    Zhu KP; Zhang CL
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
    [No Abstract]   [Full Text] [Related]  

  • 4. Down-regulation of cyclin D1 by small interfering RNA inhibits cell growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Xiao Y; Wang J; Lu J; Liu Y; Wang Y; Gao Y; Jin D
    Am J Otolaryngol; 2011; 32(6):541-6. PubMed ID: 21315488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.
    Li T; Lu J; Zhong Y
    J BUON; 2013; 18(4):908-14. PubMed ID: 24344016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma.
    Aguirre D; Boya P; Bellet D; Faivre S; Troalen F; Benard J; Saulnier P; Hopkins-Donaldson S; Zangemeister-Wittke U; Kroemer G; Raymond E
    Apoptosis; 2004 Nov; 9(6):797-805. PubMed ID: 15505422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of siRNA‑mediated Cdc2 silencing on MG63 cell proliferation and apoptosis.
    Que XY; Li Y; Han Y; Li XZ
    Mol Med Rep; 2013 Feb; 7(2):466-70. PubMed ID: 23229085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of cell apoptosis by paclitaxel and pirarubicin in a human osteosarcoma cell line.
    Liu SY; Song SX; Lin L; Liu X
    Chemotherapy; 2010; 56(2):101-7. PubMed ID: 20357441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.
    Biliran H; Wang Y; Banerjee S; Xu H; Heng H; Thakur A; Bollig A; Sarkar FH; Liao JD
    Clin Cancer Res; 2005 Aug; 11(16):6075-86. PubMed ID: 16115953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1.
    Yde CW; Issinger OG
    Int J Oncol; 2006 Dec; 29(6):1397-404. PubMed ID: 17088977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
    Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
    Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
    Lian C; Yang J; Wang X; Xie Y; Xiao Q
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
    Kothari V; Mulherkar R
    Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.
    Hua YQ; Ouyang HQ; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Liu LM
    Biomed Pharmacother; 2011 Mar; 65(2):123-31. PubMed ID: 21292437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circPVT1 Contributes to Doxorubicin (DXR) Resistance of Osteosarcoma Cells by Regulating TRIAP1 via miR-137.
    Li D; Huang Y; Wang G
    Biomed Res Int; 2021; 2021():7463867. PubMed ID: 33981772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.
    Feng T; Qiao G; Feng L; Qi W; Huang Y; Yao Y; Shen Z
    Mol Med Rep; 2014 Dec; 10(6):2985-92. PubMed ID: 25310700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of apoptosis and cell cycle related genes in proliferating and colcemid arrested cells of divergent lineage.
    Gallaher BW; Berthold A; Klammt J; Knüpfer M; Kratzsch J; Bartsch M; Kiess W
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):79-88. PubMed ID: 10726974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells.
    Wang J; Wang Q; Cui Y; Liu ZY; Zhao W; Wang CL; Dong Y; Hou L; Hu G; Luo C; Chen J; Lu Y
    J Neurooncol; 2012 Feb; 106(3):473-84. PubMed ID: 21912938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.